全球新生儿加护治疗呼吸设备市场规模（按设备类型、最终用户、区域范围和预测）

新生儿加护治疗呼吸设备市场规模及预测

2024 年新生儿加护治疗呼吸设备市场规模价值 137.2 亿美元，预计到 2032 年将达到 178.2 亿美元，预测期内（2026-2032 年）的复合年增长率为 3.66%。

新生儿加护治疗呼吸设备是一种专门的医疗设备，旨在支持早产和危重新生儿的呼吸。这些设备包括人工呼吸器、持续性阳压呼吸器(CPAP) 机和氧气输送系统。

新生儿加护治疗呼吸设备对于新生儿加护病房(NICU) 处理新生儿呼吸窘迫至关重要。 新生儿加护呼吸设备对于新生儿加护病房(NICU) 处理加护治疗呼吸窘迫至关重要。

这些设备为患有呼吸窘迫症候群、早产儿呼吸暂停和支气管肺发育不良等疾病的新生儿提供关键的呼吸支持，有助于支持肺功能和稳定呼吸模式，从而改善高风险新生儿的整体预后。

预期的技术改进将提升新生儿加护治疗呼吸设备的效率和功能，从而改善临床疗效。先进监测和自动化功能的整合将推动下一代设备的发展，确保为新生儿提供更优质的照护。

新生儿加护治疗呼吸设备的全球市场动态

影响全球新生儿加护治疗呼吸设备市场的关键市场动态是：

关键市场驱动因素

早产率上升：全球早产率上升是新生儿呼吸设备市场的主要驱动力。早产儿通常肺部发育不良，需要使用专门的呼吸支持设备，例如持续阳压呼吸器(CPAP) 系统和机械人工呼吸器来帮助他们呼吸。早产儿对呼吸支援的需求不断增长，凸显了先进呼吸支援设备在新生儿护理中的关键作用。

呼吸窘迫症候群 (RDS) 意识的提升：呼吸窘迫症候群 (RDS) 是新生儿最常见的肺部疾病，也是新生儿加护病房(NICU) 的主要死亡原因，人们对该疾病的认识日益加深，这推动了对先进呼吸设备解决方案的需求。随着医护人员和家长对 RDS 的了解日益加深，人们越来越重视获得有效可靠的呼吸设备来管理和治疗该疾病。

技术进步：该领域的技术创新推动了监测能力的增强、非侵入性通气技术的进步以及微型化设计的发展，从而提高了患者的舒适度。这些技术改进不仅提高了新生儿呼吸照护的有效性，也让设备更容易使用，更能满足新生儿的细微需求。

微创手术：新生儿照护中微创手术的趋势也是推动先进呼吸设备普及的关键因素。微创手术旨在减少患者不适和併发症风险。与传统机械通气相比，高流量氧气鼻管(HFNC) 和气泡持续性正压呼吸器 (CPAP) 系统等设备提供的呼吸支持侵入性更低，因此在新生儿护理中越来越受欢迎。

政府措施与报销：政府措施和支持性报销措施在推动新生儿呼吸设备市场成长方面发挥关键作用。改善新生儿医疗基础设施的努力，加上优惠的呼吸设备报销框架，正在提高获得先进新生儿护理的可及性。这些政府支持的措施使医院和诊所能够提供最先进的呼吸支援技术，从而改善需要呼吸支持的新生儿的预后。

主要问题

严格的监管：监管新医疗设备核准的严格法律规范也可能阻碍市场准入，并减缓新生儿患者获得先进呼吸设备技术的速度。虽然此类监管对于确保患者安全和设备有效性至关重要，但它们也可能减缓创新解决方案的引入。如何在严格的安全标准与新技术的快速部署之间取得平衡，仍然是监管机构和製造商共同关注的关键问题。

熟练劳动力短缺：缺乏经过培训、能够操作和维护先进新生儿呼吸设备的熟练医疗保健专业人员。这些先进设备需要专门的训练和专业知识才能有效使用。在缺乏训练有素人员的地区，这些技术的潜在优势可能无法充分发挥，从而限制其对新生儿护理的影响。

医院获得性感染的风险：新生儿加护病房 (NICU) 的新生儿特别容易感染医院获得性感染（简称「医院获得性感染」）。如果不遵守适当的消毒和感染控制规程，使用呼吸设备会增加这些感染疾病的风险。确保呼吸设备严格卫生并定期维护，对于最大限度地降低感染疾病风险和保护脆弱患者的健康至关重要。

新兴国家供应有限：在新兴国家，先进的新生儿呼吸设备价格高昂，且缺乏训练有素的医护人员，是取得这些设备的主要障碍。这些因素造成了救生技术在可及性和应用方面的差距，凸显了製定具有成本效益的解决方案和旨在建立当地能力的倡议的必要性。应对这些挑战需要多管齐下的方法，包括开发价格合理的设备、​​投资培训项目以及开展国际合作，以支持资源匮乏地区的医疗基础设施建设。

主要趋势

早期发现和早期疗育：新生儿呼吸窘迫的早期诊断和早期疗育对于改善预后至关重要。目前的趋势是开发能够持续监测和早期发现呼吸窘迫的设备。这种先进的监测系统旨在快速发现呼吸窘迫问题的征兆，使医护人员能够更快、更有效地介入。早期检测技术有助于预防併发症，改善呼吸窘迫新生儿的整体预后，确保及时、适当的照护。

远端医疗整合：将远端医疗解决方案整合到新生儿呼吸照护中，正在改变照护的提供方式，尤其是在新生儿加护病房(NICU) 有限的地区。远端医疗可以实现远端监控并与专家会诊，从而弥合患者与专家护理之间的差距。利用远端医疗，医疗服务提供者可以提供即时支援和指导，从而提高偏远和服务欠缺地区的新生儿护理品质。这种整合不仅提高了专科护理的可近性，还支持持续监测，以便及时处理征兆。

家庭呼吸支持：科技进步推动了为病情稳定的新生儿提供家庭呼吸支持的日益增长的趋势。这种转变需要开发适合家庭环境的便携式、易于使用的设备。家庭呼吸支援使父母能够在熟悉的环境中照顾新生儿，从而减少住院时间和相关费用。这些可携式设备设计易于使用，使父母能够有效安全地在家中管理婴儿的呼吸支持，同时在需要时仍能获得专家支持。

患者舒适度和活动能力：最大限度地减少患者不适并促进活动能力是新生儿护理的关键考虑因素。新趋势着重于开发能够允许患者更大活动范围并最大程度减少限制的呼吸设备。这些创新旨在透过减少呼吸支持方法的侵入性并允许更自然的活动来提高新生儿的舒适度。提高患者的活动能力已成为现代新生儿呼吸护理的重要方面，因为它不仅有助于促进身体发育，还能提升整体健康水平。

整合人工智慧：人工智慧 (AI) 有望透过提供先进的数据分析和决策支持，彻底改变新生儿呼吸护理。 AI 演算法可以分析大量患者数据，识别呼吸模式并预测潜在的呼吸问题，从而为临床医生提供最佳呼吸支持策略的洞察。利用 AI 可以帮助医疗保健提供者做出更明智的决策，制定个人化治疗方案，并可能改善呼吸系统疾病新生儿的预后。 AI 与呼吸照护系统的整合，代表着新生儿照护准确性和有效性的重大飞跃。

注重永续性：人们越来越重视开发环保节能的新生儿呼吸设备。这种对永续性的关注旨在促进负责任的资源管理并长期降低成本。製造商正在探索开发环境影响较小的设备的方法，包括使用可回收材料和设计更节能的系统。这些努力不仅支持全球永续性目标，还能降低医疗机构的营运成本，让先进的呼吸照护更容易取得且价格更实惠。

目录

第 1 章全球新生儿加护治疗呼吸设备市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章新生儿加护治疗呼吸设备的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球新生儿加护治疗呼吸设备市场（依设备类型）

• 概述
• 喷雾器
• 吸入器
• 人工呼吸器设备
• 持续性气道正压通气装置
• 呼吸暂停监测器
• 其他的

6. 全球新生儿加护治疗呼吸设备市场（依最终用户）

• 概述
• 新生儿加护病房
• 专科诊所
• 养老院
• 其他的

7. 全球新生儿加护治疗呼吸设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

8. 全球新生儿加护治疗呼吸设备市场的竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第九章 公司简介

• Getinge AB
• GE Healthcare
• Vyaire Medical Inc.（BD）
• Teleflex Incorporated
• Medtronic plc
• Mercury Medical
• Dragerwerk AG & Co. KGaA
• Dickinson & Company
• Inspiration Healthcare Group plc
• Trudell Medical International

第十章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十一章 附录

• 相关调查

Neonatal Intensive Care Respiratory Devices Market Size And Forecast

The Neonatal Intensive Care Respiratory Devices Market size was valued to be USD 13.72 Billion in the year 2024 and it is expected to reach USD 17.82 Billion in 2032, at a CAGR of 3.66% over the forecast period of 2026 to 2032.

Specialized medical equipment known as neonatal intensive care respiratory devices are designed to support the respiratory function of premature and critically ill newborns. Included in these devices are ventilators, continuous positive airway pressure (CPAP) machines, and oxygen delivery systems.

Essential utilization of neonatal intensive care respiratory devices occurs in neonatal intensive care units (NICUs) for managing respiratory distress in newborns. Adequate oxygenation and ventilation support are ensured for infants during critical periods through the implementation of these devices.

Vital respiratory assistance is provided by these devices to neonates experiencing conditions such as respiratory distress syndrome, apnea of prematurity, and bronchopulmonary dysplasia. Support for lung function and stabilization of breathing patterns is facilitated, leading to improved overall outcomes for at-risk infants.

Anticipated enhancements in technology are expected to improve the efficiency and functionality of neonatal intensive-care respiratory devices, leading to better clinical outcomes. Integration of advanced monitoring and automation features is likely to drive the development of next-generation devices, ensuring superior care for neonates.

Global Neonatal Intensive Care Respiratory Devices Market Dynamics

The key market dynamics that are shaping the global neonatal intensive care respiratory devices market include:

Key Market Drivers:

Rising Preterm Births: The rising incidence of preterm births globally is a significant driver for the neonatal respiratory devices market. Premature infants often have underdeveloped lungs, necessitating the use of specialized respiratory support devices such as bubble continuous positive airway pressure (CPAP) systems and mechanical ventilators to assist their breathing. This growing need for respiratory assistance in preterm newborns underscores the critical role of advanced respiratory devices in neonatal care.

Growing Awareness of RDS: Increased awareness of respiratory distress syndrome (RDS), the most common lung disorder in newborns and a leading cause of mortality in neonatal intensive care units (NICUs), further fuels demand for advanced respiratory solutions. As healthcare providers and parents become more informed about RDS, there is a heightened emphasis on obtaining effective and reliable respiratory devices to manage and treat this condition.

Technological Advancements: Innovations in this field have resulted in devices with enhanced monitoring capabilities, non-invasive ventilation techniques, and miniaturized designs that improve patient comfort. These technological improvements not only enhance the effectiveness of neonatal respiratory care but also ensure that the devices are easier to use and more adaptable to the delicate needs of newborns.

Minimally Invasive Procedures: The trend towards minimally invasive procedures in neonatal care is another key factor driving the adoption of advanced respiratory devices. Minimally invasive techniques aim to reduce patient discomfort and the risk of complications. Devices such as high-flow nasal cannula (HFNC) and bubble CPAP systems offer less invasive respiratory support compared to traditional mechanical ventilation, making them increasingly popular choices in neonatal care settings.

Government Initiatives and Reimbursement: Government initiatives and supportive reimbursement policies play a crucial role in driving the growth of the neonatal respiratory devices market. Efforts to improve neonatal healthcare infrastructure, coupled with favorable reimbursement frameworks for respiratory devices, enhance accessibility to advanced neonatal care. These government-supported initiatives ensure that hospitals and clinics can provide state-of-the-art respiratory support technologies, thereby improving outcomes for newborns requiring respiratory assistance.

Key Challenges:

Stringent Regulations: Stringent regulatory frameworks governing the approval of new medical devices can also impede market entry and delay the availability of advanced respiratory technologies for newborns. While these regulations are essential for ensuring patient safety and device efficacy, they can slow down the introduction of innovative solutions. Balancing the need for rigorous safety standards with the rapid deployment of new technologies remains a critical consideration for regulatory bodies and manufacturers alike.

Skilled Workforce Shortages: Lack of skilled healthcare professionals trained to operate and maintain sophisticated neonatal respiratory devices. The effective use of these advanced devices requires specialized training and expertise. In regions where there is a lack of trained personnel, the potential benefits of these technologies may not be fully realized, limiting their impact on neonatal care.

Nosocomial Infection Risk: Neonates in NICUs are particularly vulnerable to nosocomial, or hospital-acquired, infections. The use of respiratory devices increases the risk of these infections if proper sterilization and infection control protocols are not strictly followed. Ensuring rigorous hygiene practices and regular maintenance of respiratory equipment is crucial to minimizing the risk of infections and safeguarding the health of these vulnerable patients.

Limited Availability in Developing Countries: In developing countries, the high cost of advanced neonatal respiratory devices and the scarcity of trained healthcare personnel present substantial barriers to access. These factors contribute to a disparity in the availability and utilization of life-saving technologies, highlighting the need for cost-effective solutions and initiatives aimed at building local capacity. Addressing these challenges requires a multifaceted approach, including the development of affordable devices, investment in training programs, and international collaboration to support healthcare infrastructure in low-resource settings.

Key Trends:

Early Detection and Intervention: Early diagnosis and intervention for respiratory problems in newborns are crucial for improving outcomes. Current trends focus on the development of devices that provide continuous monitoring and early detection of respiratory distress. These advanced monitoring systems are designed to promptly identify signs of respiratory issues, allowing healthcare providers to intervene more quickly and effectively. Early detection technologies can help prevent complications and improve the overall prognosis for neonates with respiratory challenges, ensuring timely and appropriate care.

Telemedicine Integration: Integrating telemedicine solutions with neonatal respiratory care is transforming how care is delivered, particularly in regions with limited access to neonatal intensive care units (NICUs). Telemedicine enables remote monitoring and consultations with specialists, bridging the gap between patients and expert care. By utilizing telemedicine, healthcare providers can offer real-time support and guidance, improving the quality of care for newborns in remote or underserved areas. This integration not only enhances access to specialized care but also supports continuous monitoring, ensuring that any signs of distress are addressed promptly.

Home-Based Respiratory Support: Technological advancements are driving a growing trend toward providing home-based respiratory support for stable neonates. This shift requires the development of portable and user-friendly devices suitable for home settings. Home-based respiratory support allows parents to care for their infants in a familiar environment, which can reduce hospital stays and associated costs. These portable devices are designed to be easy to use, ensuring that parents can manage their infants' respiratory needs effectively and safely at home, while still having access to professional medical support when needed.

Patient Comfort and Mobility: Minimizing patient discomfort and promoting mobility are essential considerations in neonatal care. New trends focus on developing respiratory devices that allow for greater patient movement and minimize restrictions. These innovations aim to enhance the comfort of neonates by reducing the invasiveness of respiratory support methods and allowing for more natural movement. Improved patient mobility not only contributes to better physical development but also enhances overall well-being, making it a critical aspect of modern neonatal respiratory care.

AI Integration: Artificial intelligence (AI) is poised to revolutionize neonatal respiratory care by offering advanced data analysis and decision-making support. AI algorithms can analyze vast amounts of patient data to identify patterns and predict potential respiratory issues, providing clinicians with insights into optimal respiratory support strategies. By leveraging AI, healthcare providers can make more informed decisions, personalize treatment plans, and potentially improve outcomes for neonates with respiratory conditions. The integration of AI into respiratory care systems represents a significant leap forward in the precision and effectiveness of neonatal care.

Sustainability Focus: There is an increasing emphasis on developing environmentally friendly and energy-efficient neonatal respiratory devices. This sustainability focus aims to promote responsible resource management and cost reduction in the long term. Manufacturers are exploring ways to create devices that have a lower environmental impact, such as using recyclable materials and designing energy-efficient systems. These efforts not only support global sustainability goals but also reduce operational costs for healthcare facilities, making advanced respiratory care more accessible and affordable.

Global Neonatal Intensive Care Respiratory Devices Market Regional Analysis

Here is a more detailed regional analysis of the global neonatal intensive care respiratory devices market:

North America:

North America is substantially dominating the Global Neonatal Intensive Care Respiratory Devices Market and is expected to continue its dominance throughout the forecast period.

North America is a leader in the neonatal respiratory devices market, thanks to its advanced healthcare infrastructure, which includes a high concentration of specialized neonatal intensive care units (NICUs) equipped with cutting-edge respiratory devices.

The region experiences a relatively high rate of preterm births, which significantly increases the demand for respiratory support for neonates.

Efforts to prevent preterm births are ongoing, yet advancements in neonatal care have notably improved the survival rates of premature infants, further necessitating the need for sophisticated respiratory aid.

Supportive government policies and robust healthcare reimbursement systems play a crucial role in ensuring hospitals have access to the latest respiratory technologies. These policies facilitate the procurement of advanced devices, enhancing the quality of neonatal care.

Furthermore, North America's status as a hub for medical research and development fosters the creation of innovative neonatal respiratory devices, keeping the region at the forefront of technological advancements in healthcare.

The market dynamics in North America are characterized by high adoption rates of new and advanced neonatal respiratory devices, driven by the region's focus on technological innovation and improving neonatal outcomes.

There is a growing preference for minimally invasive respiratory support options, such as High Flow Nasal Cannula (HFNC), which are designed to minimize discomfort for neonates while providing effective respiratory assistance.

The presence of major companies like Philips, ResMed, and GE Healthcare dominates the North American market, driving continuous innovation and competition. These key players' commitment to developing advanced, user-friendly, and minimally invasive respiratory solutions ensures that North America remains a leader in the neonatal respiratory devices market.

Asia Pacific

The Asia Pacific (APAC) region is expected to experience the fastest growing region Global Neonatal Intensive Care Respiratory Devices Market, driven by rapidly developing economies in the region are leading to increased healthcare spending and substantial investments in enhancing neonatal care infrastructure.

This economic progress translates into a growing demand for advanced respiratory devices in neonatal intensive care units (NICUs).

Coupled with rising birth rates and an increasing number of preterm births, there is a larger patient pool requiring specialized respiratory support. This demographic trend underscores the critical need for effective neonatal respiratory care solutions.

Government initiatives across many APAC countries are prioritizing maternal and child healthcare improvements.

These initiatives include allocating funds to upgrade NICUs and equip them with essential respiratory devices, reflecting a strong commitment to improving neonatal outcomes. Such government support not only enhances the quality of care but also boosts the demand for advanced medical technologies.

While there is a growing market for high-end respiratory devices, affordability remains a crucial concern in many APAC countries. This creates a dual market dynamic where there is significant demand for both premium and cost-effective respiratory devices.

Manufacturers are thus incentivized to develop and offer a range of products that cater to diverse economic segments, ensuring broader access to life-saving technologies.

Market dynamics in the APAC region are also influenced by a surge in domestic production of neonatal respiratory devices. Factors such as lower manufacturing costs and a focus on self-reliance are driving this trend.

Domestic production not only meets local demand more efficiently but also supports regional economic growth and innovation.

Additionally, there is an increasing emphasis on early detection and intervention of neonatal respiratory problems. This proactive approach leads to a greater need for advanced and effective respiratory support technologies.

Early detection devices and interventions are essential in managing respiratory distress promptly, improving survival rates, and reducing long-term health complications for newborns.

Collectively, these factors are shaping a vibrant and rapidly expanding neonatal respiratory devices market in the Asia Pacific region.

Global Neonatal Intensive Care Respiratory Devices Market: Segmentation Analysis

The Global Neonatal Intensive Care Respiratory Devices Market is segmented based on Device Type, End-User, And Geography.

Neonatal Intensive Care Respiratory Devices Market, By Device Type

• Nebulizers
• Inhalers
• Ventilators
• Continuous Positive Airway Devices
• Apnea Monitors

Based on Device Type, the Neonatal Intensive Care Respiratory Devices Market is segmented into Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Devices, and Apnea Monitors. The Inhalers segment is experiencing significant growth in the Global Neonatal Intensive Care Respiratory Devices Market, owing to the increasing incidence of severe respiratory cases linked to extreme pollution levels. As pollution continues to escalate worldwide, leading to a gradual decline in the Air Quality Index, the demand for inhalers is expected to rise. This sector is anticipated to record higher sales in the coming years as healthcare providers seek effective solutions to manage and treat respiratory conditions in neonates affected by poor air quality.

Neonatal Intensive Care Respiratory Devices Market, By End-User

• NICU Hospitals
• Specialty Clinics
• Nursing Homes

Based on End-User, the Neonatal Intensive Care Respiratory Devices Market is segmented into NICU Hospitals, Specialty Clinics, and Nursing Homes. The NICU Hospitals segment is showing significant growth in the Global Neonatal Intensive Care Respiratory Devices Market owing to the increase in the number of premature births occurring in recent times. Owing to the number of premature births, the need for NICU facilities is becoming inevitable most of the time. It is further expected to expand.

Neonatal Intensive Care Respiratory Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Regional Analysis, the Global Neonatal Intensive Care Respiratory Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is substantially dominating the Global Neonatal Intensive Care Respiratory Devices Market and is expected to continue its dominance throughout the forecast period. North America is a leader in the neonatal respiratory devices market, thanks to its advanced healthcare infrastructure, which includes a high concentration of specialized neonatal intensive care units (NICUs) equipped with cutting-edge respiratory devices. The region experiences a relatively high rate of preterm births, which significantly increases the demand for respiratory support for neonates. Efforts to prevent preterm births are ongoing, yet advancements in neonatal care have notably improved the survival rates of premature infants, further necessitating the need for sophisticated respiratory aid.

Key Players

The "Global Neonatal Intensive Care Respiratory Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Getinge AB, GE Healthcare, Vyaire Medical Inc. (BD), Teleflex Incorporated, Medtronic plc, Mercury Medical, Dragerwerk AG & Co. KGaA, Dickinson & Company, Inspiration Healthcare Group plc, and Trudell Medical International. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Global Neonatal Intensive Care Respiratory Devices Market Key Developments

• In June 2020, Inspiration Healthcare plc paid £18 million to SLE, a provider of newborn ventilation products, following a successful funding round.
• In April 2020, during the COVID-19 pandemic, Philips debuted its readily available ventilation option, the Philips Respironics E30 ventilator. It would benefit clinics and hospitals that do not have critical care, full-featured ventilators.
• In April 2019, InnAccel announced SAANS, the world's first portable, infrastructure-independent newborn CPAP machine. It will aid critically unwell infants with RDS by providing breathing support.
• In April 2019, Dragerwerk AG & Co. KGaA gained FDA approval for the Seattle Positive Airway Pressure Plus System for neonates with respiratory distress syndrome.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY DEVICE TYPE

• 5.1 Overview
• 5.2 Nebulizers
• 5.3 Inhalers
• 5.4 Ventilators
• 5.5 Continuous Positive Airway Devices
• 5.5 Apnea Monitors
• 5.6 Others

6 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY END-USER

• 6.1 Overview
• 6.2 NICU Hospitals
• 6.3 Specialty Clinics
• 6.4 Nursing Homes
• 6.5 Other

7 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Getinge AB
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Business Breakdown
  • 9.1.4 Product Benchmarking
  • 9.1.5 Key Developments
  • 9.1.6 Winning Imperatives
  • 9.1.7 Current Focus & Strategies
  • 9.1.8 Threat from Competition
  • 9.1.9 SWOT Analysis
• 9.2 GE Healthcare
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Business Breakdown
  • 9.2.4 Product Benchmarking
  • 9.2.5 Key Developments
  • 9.2.6 Winning Imperatives
  • 9.2.7 Current Focus & Strategies
  • 9.2.8 Threat from Competition
  • 9.2.9 SWOT Analysis
• 9.3 Vyaire Medical Inc. (BD)
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Business Breakdown
  • 9.3.4 Product Benchmarking
  • 9.3.5 Key Developments
  • 9.3.6 Winning Imperatives
  • 9.3.7 Current Focus & Strategies
  • 9.3.8 Threat from Competition
  • 9.3.9 SWOT Analysis
• 9.4 Teleflex Incorporated
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Business Breakdown
  • 9.4.4 Product Benchmarking
  • 9.4.5 Key Developments
  • 9.4.6 Winning Imperatives
  • 9.4.7 Current Focus & Strategies
  • 9.4.8 Threat from Competition
  • 9.4.9 SWOT Analysis
• 9.5 Medtronic plc
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Business Breakdown
  • 9.5.4 Product Benchmarking
  • 9.5.5 Key Developments
  • 9.5.6 Winning Imperatives
  • 9.5.7 Current Focus & Strategies
  • 9.5.8 Threat from Competition
  • 9.5.9 SWOT Analysis
• 9.6 Mercury Medical
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Business Breakdown
  • 9.6.4 Product Benchmarking
  • 9.6.5 Key Developments
  • 9.6.6 Winning Imperatives
  • 9.6.7 Current Focus & Strategies
  • 9.6.8 Threat from Competition
  • 9.6.9 SWOT Analysis
• 9.7 Dragerwerk AG & Co. KGaA,
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Business Breakdown
  • 9.7.4 Product Benchmarking
  • 9.7.5 Key Developments
  • 9.7.6 Winning Imperatives
  • 9.7.7 Current Focus & Strategies
  • 9.7.8 Threat from Competition
  • 9.7.9 SWOT Analysis
• 9.8 Dickinson & Company
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Business Breakdown
  • 9.8.4 Product Benchmarking
  • 9.8.5 Key Developments
  • 9.8.6 Winning Imperatives
  • 9.8.7 Current Focus & Strategies
  • 9.8.8 Threat from Competition
  • 9.8.9 SWOT Analysis
• 9.9 Inspiration Healthcare Group plc
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Business Breakdown
  • 9.9.4 Product Benchmarking
  • 9.9.5 Key Developments
  • 9.9.6 Winning Imperatives
  • 9.9.7 Current Focus & Strategies
  • 9.9.8 Threat from Competition
  • 9.9.9 SWOT Analysis
• 9.10 Trudell Medical International
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Business Breakdown
  • 9.10.4 Product Benchmarking
  • 9.10.5 Key Developments
  • 9.10.6 Winning Imperatives
  • 9.10.7 Current Focus & Strategies
  • 9.10.8 Threat from Competition
  • 9.10.9 SWOT Analysis

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research